Prognostic significance of immunohistochemical epithelial–mesenchymal transition markers in skin melanoma patients

Author:

Pieniazek Malgorzata1,Donizy Piotr2,Halon Agnieszka2,Leskiewicz Marek3,Matkowski Rafal45

Affiliation:

1. Department of Clinical Oncology, Tadeusz Koszarowski Regional Oncology Center, Opole, Katowicka 66a, Poland

2. Department of Pathomorphology & Oncological Cytology, Wroclaw Medical University, Borowska 213, 50–556 Wroclaw, Poland

3. Department of Statistics, Wroclaw University of Economics, Komandorska 118–120, 53–345 Wroclaw, Poland

4. Department of Oncology & Division of Surgical Oncology, Wroclaw Medical University, pl. Hirszfelda 12, 53–413 Wroclaw, Poland

5. Lower Silesian Oncology Centre, pl. Hirszfelda 12, 53–413 Wroclaw, Poland

Abstract

Aim: To investigate secreted protein acidic and rich in cystein (SPARC) and neural cadherin (NCAD), which are associated with epithelial–mesenchymal transition in primary skin melanoma and nodal metastases and their prognostic impact in melanoma patients. Methods: Expression of proteins was assessed by immunochemistry in archival paraffin samples from 103 primary melanoma tumors and 16 nodal metastases. Results: Increased expression of SPARC and NCAD in primary skin melanoma was associated with decreased overall survival, adverse clinicopathological features and particularly with microsatellitosis (SPARC) and ulceration (NCAD). In univariate Cox regression analysis, both biomarkers were significantly associated with the risk of death; the multivariate Cox regression analysis identified no significance. Conclusion: The most important result of our study was that we confirmed the strict correlation between SPARC and NCAD expression and clinicopathological parameters related with melanoma progression, which is a specific clinical equivalent of the molecular mechanisms of epithelial–mesenchymal transition process and confirms its key role in the disease outcome.

Publisher

Future Medicine Ltd

Subject

Biochemistry, medical,Clinical Biochemistry,Drug Discovery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3